MGRX intends to use the net proceeds from the offering to finance the marketing and operational expenses associated with the planned marketing of its Mango ED and GROW hair growth products, to hire additional personnel to build organizational talent, to develop and maintain software, and for working capital and other general corporate purposes In an […]
Tag: Pharmaceuticals & Biotech
Dry Age-Related Macular Degeneration Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023
DelveInsight’s, “Dry Age-Related Macular Degeneration Pipeline Insight 2023” report provides comprehensive insights about 58+ Dry Age-Related Macular Degeneration companies and 64+ pipeline drugs in the Dry Age-Related Macular Degeneration pipeline landscape. It covers the Dry Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product […]
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, has announced the launch of its new Robenidine Test Reagents for the detection […]
Bronchitis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Hanlim Pharm, Ahn-Gook Pharma, Johnson & Johnson, PharmaKing, Yuhan Crp., Pfizer, Sanofi
“Bronchitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bronchitis, historical and forecasted epidemiology as well as the Bronchitis market trends in the 7MM. DelveInsight’s “Bronchitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bronchitis, historical and forecasted epidemiology as well as the Bronchitis market […]
Acute Myeloid Leukemia Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Sanofi-Aventis, Teva Pharma, Pfizer, Roche, Sunesis Pharma, Novartis
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Myeloid Leukemia pipeline constitutes 260+ key companies continuously working towards developing 260+ Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acute Myeloid Leukemia Pipeline report embraces in-depth commercial and clinical assessment […]
Parkinson’s Disease Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Parkinson’s Disease pipeline constitutes 140+ key companies continuously working towards developing 150+ Parkinson’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Parkinson’s Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]
Mangoceuticals ($MGRX) Poised for Growth: Strategic Expansion and Public Offering Set Stage for Market Surge
Mangoceuticals, Inc. (NASDAQ: MGRX) is making significant strides in the men’s health and wellness market, positioning itself for a potential surge in share value post-offering. The company’s recent public offering, coupled with strategic developments in product expansion and market penetration, particularly in Mexico and Latin America, presents a compelling case for investors and traders. Factors […]
Type 1 Diabetes Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Vertex Pharma, Avotres, Eli Lilly, Novartis, ImCyse, Tolerion, Avotres, REMD Biotherapeutics, Novo Nordisk
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Type 1 Diabetes pipeline constitutes 80+ key companies continuously working towards developing 100+ Type 1 Diabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Type 1 Diabetes Pipeline report embraces in-depth commercial and clinical assessment […]
Degenerative Disc Disease Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Mesoblast, DiscGenics, Biosplice Therapeutics
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key companies continuously working towards developing 15+ Degenerative Disc Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Degenerative Disc Disease Pipeline report embraces in-depth commercial and clinical assessment […]
Systemic Lupus Erythematosus Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Sanofi SA, Eli Lilly, Viatris, Novartis AG, GSK
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Systemic Lupus Erythematosus pipeline constitutes 55+ key companies continuously working towards developing 60+ Systemic Lupus Erythematosus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Systemic Lupus Erythematosus Pipeline report embraces in-depth commercial and clinical assessment […]